Comments
Loading...
Esperion Therapeutics Actividad de operaciones con información privilegiada
ESPRNASDAQ
Actividad de operaciones de insiders
Sigue la actividad de operaciones con información privilegiada más reciente de Esperion Therapeutics. Mantente informado sobre las compras, ventas e impacto en el mercado recientes de las acciones de Esperion Therapeutics.
¿Qué es la actividad interna?
La actividad de uso de información privilegiada involucra a personas con información privilegiada de la empresa, como ejecutivos, directores y empleados, que participan en transacciones con acciones de su propia empresa. Las transacciones de compra y venta de los iniciados proporcionan información valiosa sobre su confianza en el desempeño futuro de la empresa.
¿Qué están haciendo Esperion Therapeutics Inc los iniciados?
En Esperion Therapeutics Inc, la reciente actividad interna ha llamado la atención. Durante los últimos 30 días, los insiders han informado que han vendido un total de 1.25K acciones por valor de $3.28K, mientras tanto, los insiders han no reportar compras en los últimos 30 días.
Compras y ventas recientes notables de información privilegiada
- El octubre 20, 2025, Benjamin Looker, la empresa GENERAL COUNSEL sold 1.25K acciones por $2.62 cada una.
- El septiembre 18, 2025, Benjamin Looker, la empresa GENERAL COUNSEL sold 6.27K acciones por $2.8 cada una.
- El septiembre 18, 2025, Benjamin Halladay, la empresa CHIEF FINANCIAL OFFICER sold 7.05K acciones por $2.81 cada una.
Estadísticas de propiedad de Esperion Therapeutics Inc
Acciones en circulación
231.623M
Acciones en manos de personas con información privilegiada
4.455M
Porcentaje de acciones en manos de personas con información privilegiada
2.25%
Acciones en manos de instituciones
67.072M
Porcentaje de acciones en manos de instituciones
33.3%
Oct 20, 2025 | GENERAL COUNSEL | -1.25K | $2.62 | -$3.28K | SELL | -0.32% | 392.42K | Oct 17 | ||
Sep 18, 2025 | GENERAL COUNSEL | -6.27K | $2.80 | -$17.57K | SELL | -1.57% | 393.67K | Sep 17 | ||
Sep 18, 2025 | PRESIDENT AND CEO | -28.43K | $2.79 | -$79.25K | SELL | -1.84% | 1.52M | Sep 17 | ||
Sep 18, 2025 | CHIEF FINANCIAL OFFICER | -7.05K | $2.81 | -$19.79K | SELL | -1.46% | 474.86K | Sep 17 | ||
Jul 18, 2025 | GENERAL COUNSEL | -1.30K | $1.13 | -$1.47K | SELL | -0.32% | 399.94K | Jul 17 | ||
Jul 18, 2025 | CHIEF FINANCIAL OFFICER | -11.00 | $1.11 | -$12.27 | SELL | -0.00% | 474.46K | Jul 17 | ||
Jun 18, 2025 | GENERAL COUNSEL | -6.42K | $1.15 | -$7.40K | SELL | -1.58% | 401.24K | Jun 17 | ||
Jun 18, 2025 | PRESIDENT AND CEO | -30.47K | $1.11 | -$33.80K | SELL | -1.94% | 1.54M | Jun 17 | ||
Jun 18, 2025 | CHIEF FINANCIAL OFFICER | -7.23K | $1.15 | -$8.33K | SELL | -1.50% | 474.47K | Jun 17 | ||
Apr 21, 2025 | CHIEF COMMERCIAL OFFICER | -108.00 | $0.98 | -$105.62 | SELL | -0.03% | 370.22K | Apr 17 | ||
Apr 21, 2025 | CHIEF FINANCIAL OFFICER | -8.00 | $0.96 | -$7.71 | SELL | -0.00% | 481.70K | Apr 17 | ||
Mar 19, 2025 | CHIEF FINANCIAL OFFICER | -3.54K | $1.48 | -$5.24K | SELL | -0.73% | 481.71K | Mar 18 | ||
Mar 19, 2025 | CHIEF COMMERCIAL OFFICER | -2.43K | $1.49 | -$3.62K | SELL | -0.65% | 370.33K | Mar 18 | ||
Mar 19, 2025 | PRESIDENT AND CEO | -13.05K | $1.50 | -$19.62K | SELL | -0.82% | 1.57M | Mar 18 | ||
Feb 20, 2025 | CHIEF COMMERCIAL OFFICER | -239.00 | $1.87 | -$446.45 | SELL | -0.15% | 159.76K | Feb 19 | ||
Feb 20, 2025 | CHIEF FINANCIAL OFFICER | -11.00 | $1.86 | -$20.46 | SELL | -0.00% | 240.67K | Feb 19 | ||
Jan 21, 2025 | CHIEF FINANCIAL OFFICER | -9.00 | $2.27 | -$20.39 | SELL | -0.00% | 240.68K | Jan 17 | ||
Jan 21, 2025 | CHIEF COMMERCIAL OFFICER | -123.00 | $2.26 | -$277.98 | SELL | -0.08% | 160.00K | Jan 17 | ||
Dec 18, 2024 | CHIEF FINANCIAL OFFICER | -3.25K | $2.42 | -$7.87K | SELL | -1.33% | 240.69K | Dec 17 | ||
Dec 18, 2024 | CHIEF COMMERCIAL OFFICER | -2.23K | $2.43 | -$5.43K | SELL | -1.38% | 160.12K | Dec 17 | ||
Dec 18, 2024 | PRESIDENT AND CEO | -12.45K | $2.47 | -$30.69K | SELL | -1.65% | 739.82K | Dec 17 | ||
Nov 20, 2024 | CHIEF COMMERCIAL OFFICER | -197.00 | $2.17 | -$426.50 | SELL | -0.12% | 162.35K | Nov 19 | ||
Oct 18, 2024 | CHIEF COMMERCIAL OFFICER | -107.00 | $2.12 | -$226.73 | SELL | -0.07% | 162.55K | Oct 17 | ||
Sep 18, 2024 | PRESIDENT AND CEO | -14.55K | $1.80 | -$26.13K | SELL | -1.90% | 752.27K | Sep 17 | ||
Sep 18, 2024 | CHIEF COMMERCIAL OFFICER | -2.61K | $1.78 | -$4.65K | SELL | -1.58% | 162.66K | Sep 17 | ||
Aug 20, 2024 | CHIEF COMMERCIAL OFFICER | -211.00 | $1.95 | -$410.61 | SELL | -0.13% | 165.27K | Aug 19 | ||
Jul 19, 2024 | CHIEF COMMERCIAL OFFICER | -108.00 | $2.59 | -$279.40 | SELL | -0.07% | 165.48K | Jul 17 | ||
Jul 19, 2024 | CHIEF MEDICAL OFFICER | -917.00 | $2.60 | -$2.38K | SELL | -0.33% | 272.86K | Jul 17 | ||
Jun 20, 2024 | CHIEF MEDICAL OFFICER | -3.29K | $2.87 | -$9.42K | SELL | -1.19% | 273.78K | Jun 18 | ||
Jun 20, 2024 | CHIEF COMMERCIAL OFFICER | -2.54K | $2.86 | -$7.25K | SELL | -1.51% | 165.59K | Jun 18 | ||
May 20, 2024 | CHIEF COMMERCIAL OFFICER | -192.00 | $2.48 | -$476.74 | SELL | -0.11% | 168.13K | May 17 | ||
Sep 21, 2023 | CHIEF COMMERCIAL OFFICER | -742.00 | $1.25 | -$923.79 | SELL | -1.07% | 68.32K | Sep 20 | ||
Aug 21, 2023 | CHIEF COMMERCIAL OFFICER | -243.00 | $1.41 | -$343.60 | SELL | -0.35% | 69.06K | Aug 18 | ||
Jul 20, 2023 | CHIEF COMMERCIAL OFFICER | -106.00 | $1.58 | -$168.01 | SELL | -0.15% | 69.30K | Jul 19 | ||
Jun 22, 2023 | CHIEF COMMERCIAL OFFICER | -603.00 | $1.48 | -$894.25 | SELL | -0.86% | 69.41K | Jun 21 | ||
May 18, 2023 | CHIEF COMMERCIAL OFFICER | -219.00 | $1.62 | -$355.66 | SELL | -0.31% | 70.01K | May 17 | ||
May 11, 2023 | DIRECTOR | 31.50K | $1.55 | $48.83K | BUY | 630.00% | 36.50K | May 10 - May 11 | ||
May 11, 2023 | DIRECTOR | 8.11K | $1.50 | $12.13K | BUY | ∞ | 8.11K | May 10 | ||
May 10, 2023 | PRESIDENT AND CEO | 20.00K | $1.26 | $25.19K | BUY | 6.83% | 312.82K | May 09 | ||
Apr 20, 2023 | CHIEF COMMERCIAL OFFICER | -115.00 | $1.28 | -$146.97 | SELL | -0.16% | 70.23K | Apr 19 | ||
Apr 20, 2023 | GENERAL COUNSEL | -1.29K | $1.27 | -$1.64K | SELL | -1.52% | 83.66K | Apr 19 | ||
Apr 20, 2023 | CHIEF MEDICAL OFFICER | -938.00 | $1.27 | -$1.19K | SELL | -0.73% | 127.06K | Apr 19 | ||
Mar 20, 2023 | CHIEF MEDICAL OFFICER | -3.81K | $1.78 | -$6.79K | SELL | -2.89% | 128.00K | Mar 17 | ||
Mar 20, 2023 | PRESIDENT AND CEO | -7.00K | $1.78 | -$12.48K | SELL | -2.33% | 292.82K | Mar 17 | ||
Mar 20, 2023 | CHIEF COMMERCIAL OFFICER | -526.00 | $1.78 | -$937.49 | SELL | -0.74% | 70.35K | Mar 17 | ||
Mar 08, 2023 | CHIEF COMMERCIAL OFFICER | -5.09K | $5.05 | -$25.73K | SELL | -9.49% | 48.57K | Mar 07 | ||
Mar 08, 2023 | PRESIDENT AND CEO | -5.44K | $5.06 | -$27.51K | SELL | -2.72% | 194.81K | Mar 07 | ||
Mar 08, 2023 | CHIEF MEDICAL OFFICER | -3.88K | $5.07 | -$19.67K | SELL | -3.63% | 103.06K | Mar 07 | ||
Jan 19, 2023 | GENERAL COUNSEL | -6.35K | $7.00 | -$44.40K | SELL | -8.96% | 64.45K | Jan 18 | ||
Jan 19, 2023 | CHIEF MEDICAL OFFICER | -1.19K | $6.99 | -$8.32K | SELL | -1.10% | 106.94K | Jan 18 | ||
Oct 19, 2022 | CHIEF MEDICAL OFFICER | -942.00 | $7.69 | -$7.24K | SELL | -0.86% | 108.14K | Oct 18 | ||
Oct 19, 2022 | CHIEF COMMERCIAL OFFICER | -107.00 | $7.69 | -$822.83 | SELL | -0.20% | 53.66K | Oct 18 | ||
Sep 20, 2022 | CHIEF COMMERCIAL OFFICER | -255.00 | $6.92 | -$1.76K | SELL | -0.47% | 53.77K | Sep 19 | ||
Sep 20, 2022 | PRESIDENT AND CEO | -3.39K | $6.94 | -$23.55K | SELL | -1.68% | 198.26K | Sep 19 | ||
Aug 31, 2022 | CHIEF COMMERCIAL OFFICER | 1.00K | $7.46 | $7.46K | BUY | 1.89% | 54.02K | Aug 31 | ||
Aug 18, 2022 | CHIEF COMMERCIAL OFFICER | -199.00 | $6.82 | -$1.36K | SELL | -0.37% | 53.02K | Aug 17 | ||
Aug 08, 2022 | PRESIDENT AND CEO | 8.61K | $5.80 | $49.95K | BUY | 4.53% | 198.77K | Aug 05 | ||
Jul 20, 2022 | CHIEF MEDICAL OFFICER | -3.90K | $6.55 | -$25.55K | SELL | -3.45% | 109.08K | Jul 19 | ||
Jul 20, 2022 | CHIEF COMMERCIAL OFFICER | -431.00 | $6.58 | -$2.84K | SELL | -0.80% | 53.22K | Jul 19 | ||
Jun 21, 2022 | PRESIDENT AND CEO | -4.55K | $4.99 | -$22.72K | SELL | -2.34% | 190.16K | Jun 17 | ||
Jun 21, 2022 | CHIEF COMMERCIAL OFFICER | -256.00 | $4.90 | -$1.25K | SELL | -0.47% | 53.65K | Jun 17 | ||
Jun 03, 2022 | DIRECTOR | 5.00K | $5.64 | $28.18K | BUY | ∞ | 5.00K | Jun 02 | ||
May 18, 2022 | CHIEF COMMERCIAL OFFICER | -196.00 | $5.98 | -$1.17K | SELL | -0.36% | 53.91K | May 17 | ||
Mar 18, 2022 | PRESIDENT AND CEO | -571.00 | $4.58 | -$2.62K | SELL | -0.29% | 194.72K | Mar 17 | ||
May 26, 2021 | 10% OWNER | 100.00K | $20.22 | $2.02M | BUY | 2.28% | 4.48M | May 24 | ||
May 21, 2021 | 10% OWNER | 200.00K | $20.37 | $4.07M | BUY | 4.79% | 4.38M | May 19 | ||
May 07, 2021 | 10% OWNER | 230.00K | $20.21 | $4.65M | BUY | 5.83% | 4.18M | May 05 - May 06 | ||
Nov 04, 2020 | — | 200.00K | $25.31 | $5.06M | PURCHASE | 5.34% | 3.95M | Nov 03 |
PREGUNTAS FRECUENTES
¿Es legal el uso de información privilegiada?
Las operaciones con información privilegiada son legales siempre que se notifiquen a la Comisión de Bolsa y Valores (SEC). El comercio ilegal de valores se produce cuando la persona con información privilegiada viola un deber fiduciario o no informa de sus operaciones.
¿Cuáles son algunos ejemplos de manipulación del mercado?
Las operaciones con información privilegiada, los esquemas de pump and dump, el front running y las operaciones de lavado son ejemplos de manipulación del mercado. Los inversores que siguen el movimiento de activos con información privilegiada deben pensar atentamente por qué estos operadores con información privilegiada están negociando sus acciones antes de seguir adelante.
Explora operaciones con información privilegiada sobre todos los valores.